|
|
|
| WEDNESDAY, JULY
10, 2002 |
|
|
PLENARY SESSION 3
|
Chairpersons:
|
J.R. Patsch, Austria
S. Humphries, UK |
| 08:30 |
GENETIC ANALYSIS OF ATHEROSCLEROSIS SUSCEPTIBILITY IN THE MOUSE
J.L. Breslow, USA
|
| 09:00 |
A SYSTEMS BIOLOGY APPROACH TO THE METABOLIC
SYNDROME
J. Scott, T. Aitman, Y. Guo, R. Naoumova, J. Nicholson, C. Shoulders,
UK
|
|
|
DEBATE SESSION
|
Chairpersons:
|
K.M. Kostner, Austria
G. Assmann, Germany
|
| 09:30 |
GUIDELINES FOR THE PREVENTION OF ATHEROSCLEROTIC
DISEASES. A EUROPEAN VIEW
O. Faergeman, Denmark
|
| 10:00 |
NCEP GUIDELINES AND THE AMERICAN POINT OF
VIEW
F.M. Sacks, USA
|
| 10:30 |
Coffee Break, Poster Viewing and Exhibition Visit
|
|
|
Workshop 5: Session 1
GENETICS OF ATHEROSCLEROSIS
|
Chairpersons:
|
S. Calandra, Italy
S. Humphries, UK
|
| 11:00 |
GENE-ENVIRONMENT INTERACTION IN CORONARY ARTERY
DISEASE (CAD)
S.E. Humphries, UK
|
| 11:25 |
A
LDLR GENOMIC SCREENING STRATEGY REVEALS NOVEL AND SPLICING
REGULATORY MUTATIONS CAUSING FAMILIAL HYPERCHOLESTEROLEMIA
S. Amsellem, D. Briffaut, A. Carrie, J.P. Rabes,J.P.
Girardet, A. Fredenrich,
P. Moulin, M. Krempf, Y. Reznik, B. Vialettes, J.L.
De Gennes, E. Bruckert,
P. Benlian, France
|
| 11:38 |
HEME
OXYGENASE-1 GENOTYPE AND RESTENOSIS AFTER FEMOROPOPLITEAL
PTA: A NOVEL VASCULAR PROTECTIVE FACTOR
M. Exner , M. Schillinger, E. Minar, W.
Mlekusch, M. Muellner, C. Mannhalter,
F.H. Bach, O. Wagner, Austria, USA
|
| 11:51 |
THE
APOLIPOPROTEIN A-V GENE PREDISPOSES TO HIGH PLASMA TRIGLYCERIDES
IN FAMILIAL COMBINED HYPERLIPIDEMIA
J. Ribalta, L. Figuera, J. Fernandez-Ballart,
E. Vilella, M. Castro Cabezas,
J. Joven, Spain, The Netherlands
|
| 12:04 |
CARDIOVASCULAR
RISK MARKERS IN AN OVERWEIGHT AND NORMAL WEIGHT POPULATION
WITH OVERSAMPLING OF CARRIERS OF THE IRS-1 972ARG VARIANT
A. Jellema, E.J.M. Feskens, R.P. Mensink, W.H.M.
Saris, D. Kromhout,
The Netherlands
|
| 12:17 |
THE
5A/6A STROMELYSIN POLYMORPHISM AND ECHOGENIC PLAQUES:
DEWSBURY AND MAIDSTONE PART OF THE BRITISH REGIONAL
HEART STUDY
E. Bashiardes, M. Cariolou, M. Giffin, A. Nicolaidis,
A. Karagrigoriou,
S. Ebrahim, S.E. Humphries, Cyprus, UK
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
Workshop 6: Session 1:
HDL, REVERSE CHOLESTEROL TRANSPORT, SELECTIVE LIPID UPTAKE AND ABC
TRANSPORTERS
|
Chairpersons:
|
Y. Stein, Israel
T. Van Berkel, The Netherlands
|
| 11:00 |
THE
IN VIVO IMPORTANCE OF SR-BI AND ABCA1 FOR THE DEVELOPMENT
OF ATHEROSCLEROTIC LESIONS AND REVERSE CHOLESTEROL TRANSPORT
T. Van Berkel, J. Spijkers, R. Out, M. Hoekstra,
J. Twisk, M. Van Eck,
The Netherlands
|
| 11:25 |
REVERSE CHOLESTEROL TRANSPORT IN VIVO
O. Stein, Y. Stein, Israel
|
| 11:50 |
ROLES
OF ATP-BINDING CASSETTE TRANSPORTER A1 (ABCA1) AND SCAVENGER
RECEPTOR BI (SR-BI) DURING APOA-1 AND HDL DEPENDENT
STEROL FLUX FROM CAPILLARY ENDOTHELIAL CELLS OF THE
BLOOD-BRAIN BARRIER
U. Panzenboeck, Z. Balazs, A. Wintersperger,
A. Hrzenjak, G.M. Kostner,
W. Sattler, Austria
|
| 12:03 |
PROBUCOL INHIBITION OF ABCA1-MEDIATED CELLULAR
LIPID EFFLUX
E. Favari, F. Bernini, G.H. Rothblat, G. Kellner-Weibel, Italy,
USA
|
| 12:16 |
HETEROZYGOSITY FOR ABCA1 GENE MUTATIONS: EFFECTS ON
LIPID METABOLISM
J.A. Kuivenhoven, G.K. Hovingh, A. Van Tol, A.H.
Smelt, J.C. Fruchart,
E. Brinton, J.D. Olvos, A.H. Zwinderman, M.R. Hayden,
J.J.P. Kastelein,
The Netherlands
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
Workshop 11: Session 1:
LIPASES, LCAT AND EXCHANGE/TRANSFER PROTEINS
|
Chairpersons:
|
R. Zechner, Austria
C. Ehnholm, Finland
|
| 11:00 |
LIPASES AND LIPOPROTEIN METABOLISM: INSIGHTS FROM TRANSGENIC MICE
R. Zechner, Austria
|
| 11:25 |
FUNCTION OF LIPASES IN LIPOPROTEIN UPTAKE - A PHYSIOLOGICALLY RELEVANT
PROCESS
U. Beisiegel, Germany
|
| 11:50 |
THE LDL RECEPTOR MEDIATES LPL ENHANCED LDL
UPTAKE BUT NOT CHYLOMICRON UPTAKE INTO THE MUSCLE IN MICE
M. Merkel, J. Heeren, M. Blaeser, K. Frahm, H. Greten, Germany
|
| 12:03 |
UPTAKE INTO HEPG2 CELLS
J.G. Strauss, M. Hayn, R. Zechner, S. Frank, Austria
|
| 12:16 |
ATHEROGENICITY
OF LIPOPROTEIN LIPASE IN TRANSGENIC RABBITS
J. Fan, T. Ichikawa, H. Unoki, J. Liang, T. Koike,
S. Kitajima, T. Watanabe,
Japan
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
AWARD WINNERS FROM INDIVIDUAL ATHEROSCLEROSIS SOCIETIES IN EUROPE
AND EASTERN TRAVEL GRANTS
|
Chairpersons:
|
H. Toplak, Austria
P. Alaupovic, USA
|
| 11:00 |
LOW
HEPATIC LIPASE ACTIVITY IS A NOVEL RISK FACTOR FOR CORONARY
ARTERY DISEASE
K.A. Dugi, K. Brandauer, N. Schmidt, B. Nau,
J.G. Schneider, S. Mentz,
T. Keiper, J.R. Schaefer, M.L. Bahner, J. Kreuzer, Germany
|
| 11:13 |
XIAP
MEDIATES CELL-CYCLE ARREST AND ACTIVATES NF-KB: NEW
SURVIVAL PATHWAYS AND THEIR DESTRUCTION BY CASPASES
DURING ENDOTHELIAL APOPTOSIS
B. Levkau, K.J. Garton, N. Ferri, R.J. Nofer,
H. Baba, E.W. Raines,
G. Breithardt, Germany, USA
|
| 11:26 |
THE IMPACT OF 12-WEEK AQUATIC EXERCISE ON LIPID
AND RENAL PARAMETERS IN CHRONIC RENAL FAILURE PATIENTS
Y. Pechter, J. Maaroos, S. Mesikepp, A. Veraksits, M. Ots, Estonia
|
| 11:39 |
EO
TRAVEL GRANT WINNER: DOES INFLAMMATION PLAY IMPORTANT
ROLE IN PATHOGENESIS OF ATHEROSCLEROSIS AND ITS CLINICAL
OUTCOME?
I. Burazor, M. Burazor, S. Nagorni, J. Glasnovic,
V. Djordjevic, V. Cosic,
Z. Burazor, N. Burazor, Yugoslavia
|
| 11:52 |
CIRCULATING COLONY-FORMING UNITS FOR OSTEOCLASTS
IN CORONARY PATIENTS WITH HYPERLIPIDEMIA
O.S. Saburova, T.A. Rozhkova, E.L. Soboleva, Russia
|
| 12:05 |
INFLUENCE OF IRBESARTAN ON PLASMA CONCENTRATIONS
OF ADHESION MOLECULES AND CHEMOKINES IN CORONARY HEART DISEASE WITH DOCUMENTED
CORONARY ATHEROSCLEROSIS
I.V. Korzh, Ukraine
|
| 12:18 |
PLTP
EXPRESSION IN THE CENTRAL NERVOUS SYSTEM OF RABBITS
R. Gander, P. Eller, S. Kaser, I. Theurl, D.
Walter, T. Sauper, A. Ritsch,
J.R. Patsch, B. Foeger, Austria
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
Workshop 23: Session 1:
ATHEROSCLEROSIS GENERAL: SELECTED ABSTRACTS
|
Chairpersons:
|
M. Carrageta, Portugal
O.A. Aziz, Egypt
|
| 11:00 |
IDENTIFICATION OF ASYMPTOMATIC PATIENTS AT
INCREASED RISK OF ACUTE CORONARY EVENTS
M.F. Carrageta, Portugal
|
| 11:15 |
OB-GENE PRODUCT LEPTIN IS ABLE TO INDUCE MONOCYTIC
TISSUE FACTOR EXPRESSION
P. Quehenberger, Germany
|
| 11:28 |
A NOVEL APPROACH TO CHOLESTEROL LOWERING: LIPOPROTEIN
CHARGE CONTROL
D.L. Sparks, Canada
|
| 11:41 |
POSSIBLE INFLUENCE OF EXTREMELY LOW FREQUENCY
(ELF) ELECTROMAGNETIC RADIATION FIELDS (EMF) ON ATHEROSCLEROSIS
B.R. Henderson, G. Pfister, M. Kind, G. Boeck, G. Wick, Austria
|
| 11:54 |
INTIMAL RETENTION OF LIPOPROTEIN CHOLESTEROL
IN CAROTID ARTERIES FROM WATANABE RABBITS
S. Proctor, J.C. Mamo, Australia
|
| 12:07 |
INTRODUCING A NEW MODEL FOR STUDYING MACROPHAGE
HOMING INTO ATHEROSCLEROTIC PLAQUE IN APOE-DEFICIENT MICE
S. Litovsky, P.R. Wyde, M. Madjid, A. Akhtar, S.W. Casscells, M. Naghavi,
USA
|
| 12:20 |
DISCUSSION
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
Workshop 14:
NON-INVASIVE AND INVASIVE DETECTION OF ATHEROSCLEROSIS
|
Chairpersons:
|
U. Hoffmann, USA
H. Hodis, USA
|
| 11:00 |
NON-INVASIVE DETECTION AND CHARACTERIZATION
OF CORONARY ATHEROSCLEROTIC PLAQUE
U. Hoffmann, R. Chan, T. Brady, USA
|
| 11:25 |
NON-INVASIVE CHARACTERISATION OF CAROTID ATHEROSCLEROSIS
BY ULTRASOUND
H. Sillesen, Denmark
|
| 11:50 |
B-MODE DETECTION OF SUBCLINICAL ATHEROSCLEROSIS
H.N. Hodis, W.J. Mack, USA
|
| 12:15 |
DIAGNOSIS
OF FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN
A. Wiegman, E.J.G. Sijbrands, J. Rodenburg, J.J.P.
Kastelein,
The Netherlands
|
| 12:30 |
Lunch Break, Poster Viewing and Exhibition
Visit |
|
|
Workshop 5: Session 2:
GENETICS OF ATHEROSCLEROSIS
|
Chairpersons:
|
J. Defesche, The Netherlands
P. Benlian, France
|
| 13:30 |
ABCA1 AND ATHEROSCLEROSIS: ASSESSMENT BY CHOLESTEROL
EFFLUX AND IMT MEASUREMENTS
J.C. Defesche, J.J.P. Kastelein, K. Hovingh,
E. De Groot, S.M. Clee,
A.H. Zwinderman, M.R. Hayden, The Netherlands, Canada
|
| 13:55 |
THE LDL RECEPTOR GENE IN FH: IS THE FOUNDER
OF THE FAMILY READY TO STEP INTO THE ERA OF CLINICAL PRACTICE ?
P. Benlian, France
|
| 14:20 |
THE NADPH-OXYDASE P22PHOX C242T POLYMORPHISM
IS ASSOCIATED WITH AN INCREASED RISK OF ATHEROSCLEROSIS
M. Roest, J. Defesche, J. Kastelein, R. Voorbij, The Netherlands
|
| 14:33 |
REGULATION OF HUMAN CETP GENE PROMOTER ACTIVITY:
ROLE OF MULTIPLE BINDING SITES FOR SP1 AND SP3 TRANSCRIPTION FACTORS
W. Le Goff, M. Gu?rin, L. Petit, M.J. Chapman, J. Thillet, France
|
| 14:46 |
ALCOHOL
INTAKE MAY NOT BE PROTECTIVE AGAINST CORONARY HEART
DISEASE IN SUBJECTS WITH DEFECTIVE ALDH2 GENOTYPES
Y. Nakamura, K. Amamoto, Y. Tsujita, S. Tamaki,
Y. Ueno, Y. Kita,
T. Okamura, A. Nozaki, T. Kadowaki, H. Ueshima, Japan
|
| 15:00 |
DISCUSSION |
|
|
Workshop 6: Session 2:
HDL, REVERSE CHOLESTEROL TRANSPORT, SELECTIVE LIPID UPTAKE AND ABC
TRANSPORTERS
|
Chairpersons:
|
S. Frank, Austria
S. Yamashita, Japan
|
| 13:30 |
HDL AND OTHER FACTORS IN THE GENETICS OF
ISCHEMIC HEART DISEASE
B.G. Nordestgaard, A. Tybjaerg-Hansen, Denmark
|
| 13:55 |
MOLECULAR
MECHANISM OF CHOLESTEROL EFFLUX; INVOLVEMENT OF A MEMBER
OF THE RHO GTPASE FAMILY CDC42
S. Yamashita, K-I. Hirano, K. Tsukamoto,A. Matsuyama,
F. Matsuura,
M. Ishigami, N. Sakai, Y. Matsuzawa, Japan
|
| 14:20 |
SCAVENGER RECEPTORS PRESENT IN THE INTESTINAL
BRUSH BORDER MEMBRANE MEDIATE THE TRANSPORT OF CHOLESTEROL AND OTHER DIETARY
LIPIDS
H. Hauser, M. Werder, C-H. Han, G. Schulthess, Switzerland
|
| 14:45 |
EXOGENOUS SHORT CHAIN CERAMIDE AND SPHINGOSINE
INDUCE INTRACELLULAR CERAMIDE FORMATION AND MODULATE APO AI-ABCA1 DEPENDENT
LIPID EFFLUX
W. Drobnik, G. Liebisch, B. Lieser, R. Schifferer, G. Schmitz,
Germany
|
| 14:57 |
INCREASED INTESTINAL ABCA1 EXPRESSION CONTRIBUTES
TO THE DECREASE IN CHOLESTEROL ABSORPTION AFTER PLANT STANOL CONSUMPTION
J. Plat, R.P. Mensink, The Netherlands
|
| 15:09 |
MUTATIONS
IN THE HUMAN ATP-BINDING CASSETTE TRANSPORTERS ABCG5
AND ABCG8 IN SITOSTEROLEMIA
S. Heimerl, T. Langmann, C. Moehle, R. Mauerer,
M. Dean, F-U. Beil,
K. Von Bergmann, G. Schmitz, Germany, USA
|
| 15:21 |
VARIATION IN THE ABCA1 GENE, REVERSE CHOLESTEROL
TRANSPORT, AND ATHEROSCLEROSIS IN THE POPULATION AT LARGE. THE COPENHAGEN
CITY HEART STUDY
R. Frikke-Schmidt , B.G. Nordestgaard, G.B. Jensen, A. Tybjaerg-Hansen,
Denmark
|
|
|
Workshop 11: Session 2:
LIPASES, LCAT AND EXCHANGE/TRANSFER PROTEINS
|
Chairpersons:
|
A. Van Tol, The Netherlands
H. Dieplinger, Austria
|
| 13:30 |
MECHANISM OF LCAT ACTIVATION BY APO A-I
S. Roosebeek, F. Peelman, M. Rosseneu, Belgium
|
| 13:55 |
THE COMPLEMENTARY ROLES OF HEPATIC LIPASE
AND ENDOTHELIAL LIPASE IN HDL METABOLISM
K.A. Rye, Australia
|
| 14:20 |
PHOSPHOLIPID TRANSFER PROTEIN, A NOVEL PLAYER
IN LIPOPROTEIN METABOLISM
A. Van Tol, The Netherlands
|
| 14:33 |
CLINICAL
AND ANALYTICAL FEATURES OF A NEW CASE OF LCAT DEFICIENCY
P. Valdivielso, I. Garcia, P. Aranda, G. Martin,
C. Garcia, M.A. Frutos,
P. Gonzalez, Spain
|
| 14:46 |
CHARACTERIZATION OF THE PHOSPHOLIPID TRANSFER
PROTEIN (PLTP) SECRETED BY HEPG2 CELLS
S.L. Siggins, M. Jauhiainen, V. Olkkonen, C. Ehnholm, Finland
|
| 15:01 |
THE LIPID TRANSPORT PROTEINS LBP AND PLTP PROMOTE
REDISTRIBUTION OF ENDOTOXIN FROM HDL TO OTHER LIPOPROTEINS IN VITRO
J.H.M. Levels, A. Marquart, P.R. Abraham, A.E.
Van Den Ende,
H.O.F. Molhuizen, S.J.H. Van Deventer, J.C.M. Meijers,
The Netherlands |
|
|
Workshop 16:
NUTRITION
|
Chairpersons:
|
D. Colquhoun, Australia
K. Widhalm, Austria
|
| 13:30 |
MEDITERRASIAN - THE BEST CARDIOPROTECTIVE
CUISINE
D. Colquhoun, Australia
|
| 13:55 |
ADDITIVE EFFECT OF STEROL-ESTER MARGARINE
WITH STATIN IN LOWERING LDL CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLAEMIA
L.A. Simons, Australia
|
| 14:07 |
NUTRITIONAL FACTORS AND ATHEROSCLEROSIS: THE
FACTS
K. Widhalm, Austria
|
| 14:27 |
MEDITERRANEAN DIET AND POST-AMI RISK OF CARDIOVASCULAR
MORTALITY
R. Marchioli, F. Barzi, R.M. Marfisi, M. Woodward, Italy, Australia
|
| 14:39 |
THE ISOFLAVONE, BIOCHANIN, LOWERS LDL-CHOLESTEROL
IN MEN
P. Nestel, H. Teede, Australia
|
| 14:51 |
EFFECT OF DIETARY AND ANTISMOKING ADVICE ON
MORTALITY IN MEN DEPENDS ON CONCENTRATION OF TRIGLYCERIDES. A 22-YEAR
FOLLOW-UP STUDY
I. Ellingsen, I. Hjermann, M. Abdelnoor, E. Hjerkinn,
S. Tonstad, Norway
|
| 15:03 |
MEDITERRANEAN
DIET, AND ITS ASSOCIATION WITH CLINICAL AND BIOCHEMICAL
MARKERS RELATED TO CARDIOVASCULAR RISK: THE ATTICA STUDY
C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos,
M. Toutouza,
I. Papaioannou, A. Zeimbekis, C. Stefanadis, P. Toutouzas,
Greece
|
| 15:15 |
DISCUSSION |
|
|
Workshop 23: Session 2:
ATHEROSCLEROSIS GENERAL: SELECTED ABSTRACTS
|
|
|
Chairpersons:
|
F. Hoppichler, Austria
F. Fabiani, Spain
|
| 13:30 |
FENOFIBRATE
INCREASES HDL-ASSOCIATED PAF-ACETYLHYDROLASE. A NEW
PLEIOTROPIC EFFECT OF FIBRIC ACID DERIVATIVES?
V. Tsimihodimos, E. Bairaktari, A. Tambaki, E.
Liberopoulos, M. Elisaf,
A. Tselepis, Greece
|
| 13:42 |
HOMOZYGOUS
FAMILIAL HYPERCHOLESTEROLEMIA: NOVEL THERAPY WITH EZETIMIBE
E. Bruckert, C. Gagne, D. Gaudet, P. Sager, D.
Ponsonnet, L. Lipka,
A. LeBeaut, R. Suresh, P. Abreu, E. Veltri, France,
Canada, USA
|
| 13:54 |
CENTRAL OBESITY, ELEVATED TRIGLYCERIDES AND
LOW HIGH DENSITY LIPOPROTEIN LEVELS ARE ASSOCIATED WITH LOW DENSITY LIPOPROTEIN
SIZE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLAEMIA
H. Nawawi, K. Bador, M.R. Sara, B.A.K. Khalid, K. Yusoff, Malaysia
|
| 14:06 |
CLASSICAL
RISK FACTORS FOR ISCHEMIC HEART DISEASE AND C-REACTIVE
PROTEIN IN ACUTE CORONARY SYNDROMES
L. Bronze, J. Monge, A. Anao, J. Galvao, C. Ferreira,
J. Azevedo, A. Aleixo,
Portugal
|
| 14:18 |
GENISTEIN INHIBITS CRP-INDUCED E-SELECTIN
INDUCTION IN HUMAN AORTIC ENDOTHELIAL CELLS
M. Exner, M. Raith, B. Gmeiner, O. Wagner, S.
Kapiotis, Austria
|
| 14:30 |
THE V249I POLYMORPHISM IN THE FRACTALKINE RECEPTOR
CX3CR1 IS NOT ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE
A. Gugl, W. Renner, G. Seinost, M. Brodmann,
E. Pabst, T.C. Wascher,
B. Paulweber, B. Iglseder, E. Pilger, Austria
|
| 14:42 |
ULTRASENSITIVE
MICROSCOPY OF THE UPTAKE OF INDIVIDUAL HDL PARTICLES
VIA SCAVENGER RECEPTOR CLASS B TYPE I IN LIVING CELLS
J. Hesse, M. Sonnleitner, A. Breuer, G.J. Schuetz, M.
Doringer, H. Stangl,
Austria
|
| 14:54 |
PLATELET-MONOCYTE
CROSS TALK AND TISSUE FACTOR EXPRESSION IN STABLE ANGINA
VERSUS UNSTABLE ANGINA/NON-ST-ELEVATION MYOCARDIAL INFARCTION
C.W. Kopp, S. Steiner, D. Seidinger, N. Iordanova,
G. Maurer, E. Minar,
K. Huber, Austria
|
| 15:06 |
LONG-TERM
COMPLIANCE TO LIPID LOWERING MEDICATION AFTER GENETIC
SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA
M.A.W. Umans-Eckenhausen, J.C. Defesche, J.J.P.
Kastelein,
The Netherlands
|
| 15:18 |
DISCUSSION
|
|
|
Workshop 15:
NUCLEAR RECEPTORS AND CELL SIGNALLING
|
Chairpersons:
|
B.R. Binder, Austria
J.C. Fruchart, France
|
| 13:30 |
INFLAMMATORY ACTIVATION OF VASCULAR CELLS:
CELLULAR AND MOLECULAR MECHANISMS
B.R. Binder, Austria
|
| 13:55 |
ROLE OF NUCLEAR RECEPTORS IN LIPOPROTEIN
METABOLISM
J.C. Fruchart, France
|
| 14:20 |
THE
EFFECT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA2
(PPAR-G2) PRO12ALA VARIANT ON HYPERTENSION , GLUCOSE
AND LIPID TOLERANCE IN THE OFFSPRINGS OF FAMILIES WITH
FAMILIAR OBESITY IN SOUTH OF POLAND
A. Dembinska-Kiec, I. Wybranska, M. Malczewska-Malec,
I. Leszczynska-Golabek, B. Kiec-Wilk, A. Jabrocka, M.
Kwasniak, M. Motyka,
Poland
|
| 14:35 |
COMPARISON OF THE EFFECT OF PPARALPHA, APO
E2, LPL OR LDL-RECEPTOR GENE MUTATIONS ON THE CHOLESTEROL AND TRIGLYCERIDE
CONTENT OF APOB CONTAINING LIPOPROTEINS (VLDL, IDL, LDL): IS THERE ANY
CLINICAL IMPLICATION?
D. Brisson, M-C. Vohl, P. Perron, T.J. Hudson, D. Gaudet, Canada,
USA
|
| 14:50 |
PPAR
GAMMA COACTIVATOR-1 RECRUITMENT REGULATES PPAR SUBTYPE
SPECIFICITY
H. Oberkofler, H. Esterbauer, V. Linnemayr, D.
Strosberg, F. Krempler,
W. Patsch, Austria, France
|
| 15:05 |
DISCUSSION
|
|
|
CLOSING SESSION
|
| 15:45 |
MEMBERS OF THE PROGRAMME COMMITTEE AND THE EAS COUNCIL
G.M. Kostner
K.M. Kostner
U. Beisiegel
|
| |
|
| | |